Companies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...

Investors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...

Bill Cassidy is the first elected U.S. senator to lose re-nomination since 2012. Former Republican Senator Richard Lugar was the last elect...

The United States is accelerating research into psychedelic drugs for mental illness. This shift prompts India to re-evaluate its own drug ...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

India Pharma Conference: India is set to become a global leader in advanced medicines like biologics and biosimilars, Union Minister J P Na...

Defence Minister Rajnath Singh highlighted the need for clinical trial reforms in India. He suggested the Armed Forces Medical Services can...

In a major policy shift, the Indian government has waived local clinical trial requirements for drugs and vaccines approved by major intern...

The joint report by the USA India Chamber of Commerce & PwC India titled, “Clinical Trial opportunities in India” which will be released at...

Experts are discussing whether administering a placebo to volunteers in a clinical trial is necessary in order to assess the safety and eff...

A global coalition of aid organisations, government agencies and academic institutions will facilitate the clinical trials of Covid-19 drug...

This assumes significance as almost half of clinical trials go unreported currently, and the move will enhance access to crucial data for m...

A team of Indian officials led by G N Singh, Drug Controller General of India, said a set of new procedures to facilitate clinical trials a...

For all those who participate in clinical trials, it may come as a shock that the data about their trials may never be published.

The National Institute of Health (NIH), has suspended its clinical trials in India in the wake of the country toughening its regulatory nor...

The health ministry has set up a seven-member expert committee to formulate policy framework for the approval of new drugs and clinical tri...

With a constant rise in the number of clinical trials in the country, clinical trial insurance is gaining momentum too.